Call us at 702-998-8009 for more information
As for placement in store, it varies by retailer, with some stocking Superguts products in the protein and meal replacement section, others in the digestive health set, and others in nascent GLP-1 sets, which encompass both companion products for people taking these medications, and alternatives for people that cant tolerate or afford them
When combined with a reduced-calorie diet and increased physical activity, clinical trials (primarily the STEP 1 trial in adults without diabetes) have shown that Wegovy can help patients lose an average of 1215% of their body weight over 68 weeks, though individual results vary
Tirzepatide, a newer dual GLP-1/GIP receptor agonist, demonstrated even larger reductions in some studies, with systolic decreases reaching 68 mmHg in overweight patients
There are questions about safety, quality, and long-term effects
15 to Rs